Rongjun Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers at Imperial College London have designed drug delivery nanocapsules that could reduce side effects of a major blood clot dissolving drug.

Imperial scientists have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug.

Date Time Blood clot-busting nanocapsules could reduce existing treatment’s side effects Imperial researchers have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug. Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot dissolving drug, which include bleeding on the brain. If confirmed with animal tests, the nanocapsules could also make the drug more effective at lower doses. We have wrapped (the drug) in a package that extends this therapeutic window and minimises the requi...

7 Min Read The safety fact sheet that social media users are sharing as alleged proof of the harmful nature of the lipid SM-102 in the Moderna COVID-19 vaccine, is actually describing the dangers of chloroform. The fact sheet is for SM-102 supplied by biotechnology company Cayman Chemical as a solution in chloroform, meaning it is made up of 90% chloroform and 10% SM-102, where chloroform is listed as the only dangerous component. The posts (here , here , here , here) display a video or screenshots indicating that SM-102 is an ingredient in the Moderna COVID-19 vaccine, followed by a Cayman C...